Efficacy News and Research

RSS

New guidelines to improve palliative care at the end of life

The American College of Physicians (ACP) has issued new guidelines to improve palliative care at the end of life (EOL).

15 Jan 2008

Study finds most psychiatric patients have more than one diagnosis

A new study by Rhode Island Hospital researchers reports that the majority of 2,300 psychiatry outpatients had more than one disorder when seeking treatment, and more than one-third had at least three disorders.

15 Jan 2008

Morphotek announces agreement for development of antibodies to treat prostate cancer

Morphotek, Inc., a subsidiary of Eisai Co., Ltd., has announced that it has signed a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI) for the development of therapeutic antibodies to a cancer-associated protein identified by NCI researchers.

10 Jan 2008

Help with getting off the couch

It's only been a few weeks since you made that New Year's resolution to exercise more, but already you're finding reasons to skip days - maybe even weeks.

10 Jan 2008

Call for an Australian crackdown on complementary and alternative medicines

A team of Australian researchers says there is an urgent need for the overhaul of the regulation of complementary medicines.

9 Jan 2008

Drug metformin and lifestyle changes can help treat weight gain induced by antipsychotic drugs

Lifestyle intervention and the drug metformin are both effective against antipsychotic-induced weight gain, and treatment is most effective when the two therapies are combined, according to a study in the January 9/16 issue of JAMA.

9 Jan 2008

Rockefeller University funds clinical, translational pilot studies

The Rockefeller University Center for Clinical and Translational Science (CCTS) has announced the recipients of its 2008 Pilot Project grants.

8 Jan 2008

Oncolytics Biotech announces new reovirus, cyclophosphamide research

Oncolytics Biotech Inc. has reported that a research group led by Dr. Richard Vile of the Mayo Clinic College of Medicine in Rochester, Minnesota, published the results of its work testing the antitumor efficacy and safety of various combinations of reovirus and cyclophosphamide in vivo.

8 Jan 2008

A look at China's most innovative health biotechnology companies

Government funds innovation but venture capital needed; Wary investors 'need to be shown the exits'; Returning 'sea turtles' bring expertise, international credibility

8 Jan 2008

Takeda submits NDA for Alogliptin (SYR-322) in the U.S.

Takeda Pharmaceutical Company Limited (Takeda) has announced that Takeda Global Research & Development Center, Inc. submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for alogliptin (development code: SYR-322), a highly selective dipeptidyl peptidase-4 (DPP-4) inhibitor under investigation for the treatment of type 2 diabetes.

7 Jan 2008

Rib-X Pharmaceuticals initiates two separate Phase II clinical trials for antibiotic compound

Rib-X Pharmaceuticals, Inc. has announced the enrolment of the first patients in two separate Phase 2 clinical trials.

7 Jan 2008

Treating children with severe pneumonia at home is just as effective as treating them in hospitals

The study results could significantly change the way the illness is managed in developing countries, saving a significant number of lives every year and taking pressure off health systems.

7 Jan 2008

Exercise improves symptoms of arthritis

Patients with arthritis, the country's leading cause of disability, tend to be less fit than their peers who don't have this condition.

7 Jan 2008

Daiichi Sankyo, Lilly submit NDA for investigational antiplatelet drug, Prasugrelin U.S.

Daiichi Sankyo Company, Limited and Eli Lilly and Company have announced that on Wednesday, Dec. 26, 2007, they submitted a New Drug Application (NDA) for prasugrel to the U.S. Food and Drug Administration (FDA).

7 Jan 2008

Magnetic therapy shown to significantly reduce swelling after tissue trauma

A recent study by University of Virginia researchers demonstrates that the use of an acute, localized static magnetic field of moderate strength can result in significant reduction of swelling when applied immediately after an inflammatory injury.

4 Jan 2008

No excess cardiovascular risk from HRT for most patients

An American Association of Clinical Endocrinologists (AACE) analysis of several studies monitoring the impact of Hormone Replacement Therapy (HRT) shows young women in early menopause may not only have no increased cardiovascular risk from the therapy, but may indeed show benefit in the future.

3 Jan 2008

Use of opioid medications for pain in ERs on the rise, but racial differences in use still exist

In the last 15 years, use of opioid medications to treat patients with pain-related emergency department visits has improved although white patients were more likely to receive opioids than patients of a different race/ethnicity, according to a study in the January 2 issue of JAMA: The Journal of the American Medical Association.

2 Jan 2008